Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Incyte Corp., 3 years.
Incyte Corp.
Director
Xilio Therapeutics Inc.
Director
Sionna Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Incyte Corp. June 10, 202594.5%
-
Incyte Corp. June 12, 202495.0%
-
Incyte Corp. June 14, 202394.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Incyte Corp. | Grant or award | +252 | $113.36 | $28,567 |
| Jun 8, 2026 | Incyte Corp. | Grant or award | +1,642 | — | — |
| May 19, 2026 | Incyte Corp. | Option exercise | +15,000 | $84.53 | $1,267,950 |
| May 19, 2026 | Incyte Corp. | Open-market sale | −15,000 | $94.93 | $1,423,950 |
| Mar 31, 2026 | Incyte Corp. | Grant or award | +265 | $94.12 | $24,942 |
| Dec 31, 2025 | Incyte Corp. | Grant or award | +241 | $98.77 | $23,804 |
| Sep 30, 2025 | Incyte Corp. | Grant or award | +285 | $84.81 | $24,171 |
| Jun 30, 2025 | Incyte Corp. | Grant or award | +361 | $68.10 | $24,584 |
| Jun 10, 2025 | Incyte Corp. | Grant or award | +2,518 | — | — |
| Mar 31, 2025 | Incyte Corp. | Grant or award | +358 | $60.55 | $21,677 |
| Dec 31, 2024 | Incyte Corp. | Grant or award | +331 | $69.07 | $22,862 |
| Sep 30, 2024 | Incyte Corp. | Grant or award | +368 | $66.10 | $24,325 |
| Jun 28, 2024 | Incyte Corp. | Grant or award | +399 | $60.62 | $24,187 |
| Jun 12, 2024 | Incyte Corp. | Grant or award | +2,830 | — | — |
| Mar 28, 2024 | Incyte Corp. | Grant or award | +403 | $56.97 | $22,959 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.